Zymeworks Inc
NASDAQ:ZYME

Watchlist Manager
Zymeworks Inc Logo
Zymeworks Inc
NASDAQ:ZYME
Watchlist
Price: 13.59 USD -2.02% Market Closed
Market Cap: 965.6m USD
Have any thoughts about
Zymeworks Inc?
Write Note

Zymeworks Inc
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zymeworks Inc
Other Current Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Zymeworks Inc
NASDAQ:ZYME
Other Current Liabilities
$8.7m
CAGR 3-Years
-32%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Current Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Other Current Liabilities
$3.2B
CAGR 3-Years
95%
CAGR 5-Years
282%
CAGR 10-Years
29%
Amgen Inc
NASDAQ:AMGN
Other Current Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Current Liabilities
$279.3m
CAGR 3-Years
7%
CAGR 5-Years
33%
CAGR 10-Years
21%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Current Liabilities
$586m
CAGR 3-Years
4%
CAGR 5-Years
0%
CAGR 10-Years
24%

See Also

What is Zymeworks Inc's Other Current Liabilities?
Other Current Liabilities
8.7m USD

Based on the financial report for Jun 30, 2024, Zymeworks Inc's Other Current Liabilities amounts to 8.7m USD.

What is Zymeworks Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
-16%

Over the last year, the Other Current Liabilities growth was -59%. The average annual Other Current Liabilities growth rates for Zymeworks Inc have been -32% over the past three years , -16% over the past five years .

Back to Top